Your browser doesn't support javascript.
loading
Pertuzumab: new hope for patients with HER2-positive breast cancer.
Capelan, M; Pugliano, L; De Azambuja, E; Bozovic, I; Saini, K S; Sotiriou, C; Loi, S; Piccart-Gebhart, M J.
Affiliation
  • Capelan M; Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels; BrEAST Data Center, Institute Jules Bordet, l'Université Libre de Bruxelles, Brussels.
  • Pugliano L; Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels; Breast International Group (BIG), Brussels.
  • De Azambuja E; Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels; BrEAST Data Center, Institute Jules Bordet, l'Université Libre de Bruxelles, Brussels.
  • Bozovic I; Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels; BrEAST Data Center, Institute Jules Bordet, l'Université Libre de Bruxelles, Brussels.
  • Saini KS; Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels; Breast International Group (BIG), Brussels.
  • Sotiriou C; Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels; Breast Cancer Translational Research Laboratory (BCTL) JC Heuson, Institut Jules Bordet, Brussels, Belgium.
  • Loi S; Breast International Group (BIG), Brussels; Breast Cancer Translational Research Laboratory (BCTL) JC Heuson, Institut Jules Bordet, Brussels, Belgium.
  • Piccart-Gebhart MJ; Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels; Breast International Group (BIG), Brussels. Electronic address: martine.piccart@bordet.be.
Ann Oncol ; 24(2): 273-282, 2013 Feb.
Article in En | MEDLINE | ID: mdl-22910839
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Antibodies, Monoclonal, Humanized / Antineoplastic Agents Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2013 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Antibodies, Monoclonal, Humanized / Antineoplastic Agents Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2013 Type: Article